Alternative delivery method could improve compliance in developing countries

The Southern Times, a news paper for southern Africa, recently looked at how developing a new delivery method for tuberculosis could improve compliance, and in turn, reduce the number of TB cases in South Africa. It's the 22nd most burdened country in the world by this particular disease, but compliance with TB medication could easily reduce the number of those infected.

While developing a weekly pill, which would deliver the medication into the blood stream slowly through the use of nanoparticles, South Africans would no longer have to take a pill daily, which has proven to cause many compliance problems. While there are worries over the cost of the research and development into the transition into weekly pills, it is believed that it would pay for itself in other ways including savings in treatment costs and substantial gains in health.

To read the entire case study, visit The Southern Times.

This year, DDP has a track focusing on New Areas of Drug Delivery Resulting from Patent Expirations. We invite you to hear from companies such as Noven Pharmaceuticals, Abraxis Bioscience, Amgen, and Genzyme discuss their developing forms of drug delivery. Download the Drug Delivery Partnerships brochure to find out more.